Neurones Price To Sales vs. EBITDA
| NRO Stock | EUR 44.90 0.05 0.11% |
For Neurones profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Neurones to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Neurones utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Neurones's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Neurones over time as well as its relative position and ranking within its peers.
Neurones |
Neurones EBITDA vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Neurones's current stock value. Our valuation model uses many indicators to compare Neurones value to that of its competitors to determine the firm's financial worth. Neurones is considered to be number one stock in price to sales category among its peers. It also is considered to be number one stock in ebitda category among its peers totaling about 48,061,530 of EBITDA per Price To Sales. Comparative valuation analysis is a catch-all model that can be used if you cannot value Neurones by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Neurones' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Neurones EBITDA vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Neurones |
| = | 1.50 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Neurones |
| = | 72.17 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Neurones EBITDA Comparison
Neurones is currently under evaluation in ebitda category among its peers.
Neurones Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Neurones, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Neurones will eventually generate negative long term returns. The profitability progress is the general direction of Neurones' change in net profit over the period of time. It can combine multiple indicators of Neurones, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Neurones S.A., an information technology services company, provides infrastructure, application, and consulting services in France and internationally. Neurones S.A. was founded in 1985 and is headquartered in Nanterre, France. NEURONES operates under Information Technology Services classification in France and is traded on Paris Stock Exchange. It employs 5160 people.
Neurones Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Neurones. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Neurones position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Neurones' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Neurones without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Use Investing Themes to Complement your Neurones position
In addition to having Neurones in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Funds Thematic Idea Now
Money Funds
Funds or Etfs that invest most if their asset in companies from financial sector such as commercial banks, insurance companies, investment funds, and real estate. The Money Funds theme has 35 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Neurones Stock
To fully project Neurones' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Neurones at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Neurones' income statement, its balance sheet, and the statement of cash flows.